DefinitiveSurgeryPathologicResponseLymphoscintigraphyDimplingDoxorubicinGeneticPredispositionOligometastasesImmunotherapymTORInhibitorsLapatinibOvarianSuppressionMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltDoseDenseTherapyKappaEpsilonCDK4/6InhibitorsBreastTomosynthesisAlopeciaAdjuvantTherapyFamilyHistoryBOCABRCAGeneAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerTamoxifenFISHCMFChemotherapyBreastCancerMetastasisEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMultifocalTumorsTriple +/-BreastCancerGuaranteedRenewableInsuranceProgestinPaclitaxelAngiogenesisIntraductalPapillomaBrachytherapyCapecitabinePARPInhibitorsGailModelACChemotherapyPhyllodesTumorHormoneReceptorStatusMastodyniaMastectomyChemotherapyPalbociclibKi-67RateWomen ages40+ shouldhave a clinicalbreast examat least yearlyCalcifications5-FluorouracilAyurveda1 in 8womenMegestrolAcetateMultimodalityTherapyER+/-AnastrozoleMorpheaEGFRRaloxifeneAdvocacyBevacizumabBI-RADSHormoneReplacementTherapyAntiemeticsLumpEstrogen/EstradiolGeneMutationNeoadjuvantTherapyCytotoxicCytostaticECOGScoreBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55SERMPagetDiseaseRADRadiotherapyStagingAbsoluteRiskFibroadenomaHER-2LumpectomyBilateralProphylacticMastectomyApoptosisSelf-examinationTumorGradeDocetaxelMethotrexateCheckpointInhibitorPrecisionMedicineCystLymphNodeStatusCachexiaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PalpationDown-StagingChemopreventionIn-situCarcinomaLCISCyclophosphamideGeneticCounselingAromataseInhibitorsFlowCytometryBiopsyPI3KinaseInhibitorsAntibodyTherapyTyrosine-KinaseInhibitorRelapseGermlineMutationMRIHerceptinCo-survivorPhysicalactivity mayreduce therisk of breastcancersAdenocarcinomaAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCAMFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.DefinitiveSurgeryPathologicResponseLymphoscintigraphyDimplingDoxorubicinGeneticPredispositionOligometastasesImmunotherapymTORInhibitorsLapatinibOvarianSuppressionMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltDoseDenseTherapyKappaEpsilonCDK4/6InhibitorsBreastTomosynthesisAlopeciaAdjuvantTherapyFamilyHistoryBOCABRCAGeneAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerTamoxifenFISHCMFChemotherapyBreastCancerMetastasisEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMultifocalTumorsTriple +/-BreastCancerGuaranteedRenewableInsuranceProgestinPaclitaxelAngiogenesisIntraductalPapillomaBrachytherapyCapecitabinePARPInhibitorsGailModelACChemotherapyPhyllodesTumorHormoneReceptorStatusMastodyniaMastectomyChemotherapyPalbociclibKi-67RateWomen ages40+ shouldhave a clinicalbreast examat least yearlyCalcifications5-FluorouracilAyurveda1 in 8womenMegestrolAcetateMultimodalityTherapyER+/-AnastrozoleMorpheaEGFRRaloxifeneAdvocacyBevacizumabBI-RADSHormoneReplacementTherapyAntiemeticsLumpEstrogen/EstradiolGeneMutationNeoadjuvantTherapyCytotoxicCytostaticECOGScoreBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55SERMPagetDiseaseRADRadiotherapyStagingAbsoluteRiskFibroadenomaHER-2LumpectomyBilateralProphylacticMastectomyApoptosisSelf-examinationTumorGradeDocetaxelMethotrexateCheckpointInhibitorPrecisionMedicineCystLymphNodeStatusCachexiaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PalpationDown-StagingChemopreventionIn-situCarcinomaLCISCyclophosphamideGeneticCounselingAromataseInhibitorsFlowCytometryBiopsyPI3KinaseInhibitorsAntibodyTherapyTyrosine-KinaseInhibitorRelapseGermlineMutationMRIHerceptinCo-survivorPhysicalactivity mayreduce therisk of breastcancersAdenocarcinomaAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCAMFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Definitive Surgery
  2. Pathologic Response
  3. Lymphoscintigraphy
  4. Dimpling
  5. Doxorubicin
  6. Genetic Predisposition
  7. Oligometastases
  8. Immunotherapy
  9. mTOR Inhibitors
  10. Lapatinib
  11. Ovarian Suppression
  12. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  13. Dose Dense Therapy
  14. Kappa Epsilon
  15. CDK4/6 Inhibitors
  16. Breast Tomosynthesis
  17. Alopecia
  18. Adjuvant Therapy
  19. Family History
  20. BOCA
  21. BRCA Gene
  22. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  23. Tamoxifen
  24. FISH
  25. CMF Chemotherapy
  26. Breast Cancer
  27. Metastasis
  28. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  29. Multifocal Tumors
  30. Triple +/- Breast Cancer
  31. Guaranteed Renewable Insurance
  32. Progestin
  33. Paclitaxel
  34. Angiogenesis
  35. Intraductal Papilloma
  36. Brachytherapy
  37. Capecitabine
  38. PARP Inhibitors
  39. Gail Model
  40. AC Chemotherapy
  41. Phyllodes Tumor
  42. Hormone Receptor Status
  43. Mastodynia
  44. Mastectomy
  45. Chemotherapy
  46. Palbociclib
  47. Ki-67 Rate
  48. Women ages 40+ should have a clinical breast exam at least yearly
  49. Calcifications
  50. 5-Fluorouracil
  51. Ayurveda
  52. 1 in 8 women
  53. Megestrol Acetate
  54. Multimodality Therapy
  55. ER +/-
  56. Anastrozole
  57. Morphea
  58. EGFR
  59. Raloxifene
  60. Advocacy
  61. Bevacizumab
  62. BI-RADS
  63. Hormone Replacement Therapy
  64. Antiemetics
  65. Lump
  66. Estrogen/Estradiol
  67. Gene Mutation
  68. Neoadjuvant Therapy
  69. Cytotoxic
  70. Cytostatic
  71. ECOG Score
  72. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  73. SERM
  74. Paget Disease
  75. RAD
  76. Radiotherapy
  77. Staging
  78. Absolute Risk
  79. Fibroadenoma
  80. HER-2
  81. Lumpectomy
  82. Bilateral Prophylactic Mastectomy
  83. Apoptosis
  84. Self-examination
  85. Tumor Grade
  86. Docetaxel
  87. Methotrexate
  88. Checkpoint Inhibitor
  89. Precision Medicine
  90. Cyst
  91. Lymph Node Status
  92. Cachexia
  93. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  94. Palpation
  95. Down-Staging
  96. Chemoprevention
  97. In-situ Carcinoma
  98. LCIS
  99. Cyclophosphamide
  100. Genetic Counseling
  101. Aromatase Inhibitors
  102. Flow Cytometry
  103. Biopsy
  104. PI3 Kinase Inhibitors
  105. Antibody Therapy
  106. Tyrosine-Kinase Inhibitor
  107. Relapse
  108. Germline Mutation
  109. MRI
  110. Herceptin
  111. Co-survivor
  112. Physical activity may reduce the risk of breast cancers
  113. Adenocarcinoma
  114. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  115. CAM
  116. For every 1,000 screening mammograms performed, about five breast cancers are detected.